Revance Therapeutics, Inc. (RVNC)

NASDAQ: RVNC · IEX Real-Time Price · USD
4.900
-0.040 (-0.81%)
Mar 28, 2024, 11:17 AM EDT - Market open

Revance Therapeutics Market Cap

Revance Therapeutics has a market cap or net worth of $514.83 million as of March 28, 2024. Its market cap has decreased by -81.04% in one year.

Market Cap
514.83M
Enterprise Value
738.80M
1-Year Change
-81.04%
Ranking
Category
Stock Price
$4.90

Market Cap Chart

Since February 6, 2014, Revance Therapeutics's market cap has increased from $453.20M to $514.83M, an increase of 13.60%. That is a compound annual growth rate of 1.27%.

History

DateMarket Cap% Change
Mar 27, 2024435.80M5.11%
Mar 26, 2024414.60M1.07%
Mar 25, 2024410.20M-4.52%
Mar 22, 2024429.60M-6.16%
Mar 21, 2024457.80M2.37%
Mar 20, 2024447.20M2.83%
Mar 19, 2024434.90M-0.21%
Mar 18, 2024435.80M-6.88%
Mar 15, 2024468.00M-2.30%
Mar 14, 2024479.00M-9.79%
Mar 13, 2024531.00M-4.22%
Mar 12, 2024554.40M0.40%
Mar 11, 2024552.20M4.15%
Mar 8, 2024530.20M-2.43%
Mar 7, 2024543.40M-2.84%
Mar 6, 2024559.30M-2.46%
Mar 5, 2024573.40M7.08%
Mar 4, 2024535.50M-13.03%
Mar 1, 2024615.70M-2.24%
Feb 29, 2024629.80M26.14%
Feb 28, 2024499.30M-0.24%
Feb 27, 2024500.50M0.16%
Feb 26, 2024499.70M3.65%
Feb 23, 2024482.10M3.39%
Feb 22, 2024466.30M-1.12%
View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
CareDx 495.52M
Replimune Group 494.17M
IGM Biosciences 493.81M
Lyell Immunopharma 487.86M
Esperion Therapeutics 484.84M
MultiPlan 482.44M
Marinus Pharmaceuticals 481.40M
Alto Neuroscience 480.71M
Market Cap Rankings